Sanofi-Aventis

174, avenue de France
F-75013 Paris


France
Europe
Tel: +33 1 53 77 40 00
Fax: +33 1 53 77 42 96
IR@sanofi-aventis.com
www.sanofi-aventis.com

Fortune Global 500 Ranking:		321
Date of Establishment:		2004
Employees:		96,439
Ticker:		New York: SNY
SIC Codes:		2819 2833 2834 2844 2869 3841
Sector:		Pharmaceuticals

ACTIVITIES OVERVIEW

Sanofi-Aventis was formed as a result of the acquisition of Aventis by Sanofi-Synthélabo in August 2004. The Company is the third largest pharmaceutical company in the world

The Company operates through two business segments:-

. Pharmaceutical: comprising six therapeutic areas of Cardiovascular - Thrombosis - Metabolic Disorders - Oncology - Central Nervous System - Internal Medicine.
. Vaccines: comprising six areas of Paediatric combination vaccines - Influenza vaccines - Polio vaccines - Adult and Adolescent booster vaccines - Meningitis vaccines - Travel vaccines

more...

FULL COMPANY PROFILES INCLUDE*:-

Selected financial information over 4 years to include revenue, profit before tax, net income, shareholders' equity, total assets, earnings per share and dividends per share

Full contact details

Analyst coverage

Consolidated and condensed data and quick facts such as revenues by segment, market share, geographical segment information, return on equity, R&D expenditure etc

List of competitors

Board of Directors

Key management & decision makers

Executive biographies

Activities overview and company background

Directory of locations

Tradenames

Date of establishment

Number of employees

SIC codes

Ticker symbol / company type

* where available

BUY THIS PROFILE NOW